Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/1630
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRashidova F.M., Abdukadyrova M.U., Nuruzova Z.A., Zalyalieva M.V.-
dc.date.accessioned2022-01-06T11:02:47Z-
dc.date.available2022-01-06T11:02:47Z-
dc.date.issued2021-
dc.identifier.issn2181-7812-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/1630-
dc.description.abstractAbstract. An outbreak of severe acute and respiratory Covid-19 infection in China has led to its global spread and has become a pandemic (WHO 2020). This disease is characterized by the following clinical manifestations: asymptomatic, mild, moderate and severe. According to the results of numerous studies, individual characteristics of the organism, depending on the state of the immune system, play a decisive role in the development of the disease. These features include age, gender, and concomitant diseases. People of the elderly and senile age (65+) are at the greatest risk, which is associated with such concomitant chronic diseases as arterial hypertension, diabetes mellitus, obesity, lung diseases, smokers, chronic hepatitis [1,2]. PCR analysis of biomaterial is the main reliable laboratory method for confirming the presence of a disease. The presence and period of the disease is confirmed by the quantitative and qualitative method of CLIA for the determination of IgG and IgM.en_US
dc.language.isootheren_US
dc.publisherTashkenten_US
dc.titleANALYSIS OF CLINICAL AND LABORATORY STUDIES OF PATIENTS WITH COVID-19en_US
dc.typeThesisen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
ttaa-spec-issue-for-onlyenglish.pdfANALYSIS OF CLINICAL AND LABORATORY STUDIES OF PATIENTS WITH COVID-19960.49 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.